Hemostemix Inc (TSXV:HEM)
C$ 0.07 -0.01 (-12.5%) Market Cap: 9.85 Mil Enterprise Value: 14.56 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Hemostemix Inc Annual Shareholders Meeting Transcript

Jun 09, 2023 / 05:00PM GMT
Release Date Price: C$0.115 (-4.17%)
Thomas A. Smeenk;Loran Swanberg
Hemostemix Inc. - Co-Founder, President, CEO & Director

Welcome to the Annual General and Special Meeting of the Shareholders of Hemostemix Inc. My name is Thomas Smeenk. I'm the President and CEO, and I will -- I am pleased to act as Chairman of the meeting today.

Thank you for recording your votes by the online proxy voting system. As this meeting is only being held via Zoom, as there's no ability of the scrutineer to properly conduct a vote from the floor, tabulate and verify the results, all voting is conducted by proxy and will be recorded according to the votes that were registered by Computershare.

The meeting will now come to order, and if there are no objections, I request Loran Swanberg to act as Secretary of the meeting; and Pauline Osayande of Computershare Trust Company to act as scrutineer for the meeting.

I will now request the Secretary to confirm proof of mailing of the notice of meeting, formal pharma proxy and Management Information Circular that was sent to the registered shareholders of the corporation.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot